RPh on the Go USA, Inc.

An FDA advisory committee recently suggested that the labeling for the diabetes drug Avandia be changed to reflect concern about the increased risk of heart disease associated with the medication. A recently released study compares the increased risk of heart

The Senate has unanimously passed S. 3397, the Secure and Responsible Drug Disposal Act, to allow patients to return unused medications safely and legally. Prior to the bill, medications that qualified as controlled substances could only be returned to authorized

A recent study suggests a significant link between heavy acetaminophen use in adolescents and an increased risk of asthma and eczema. The study questioned 13 and 14 year olds as to their use of acetaminophen and the occurrence of asthma

Pharmacy quality control is a benefit to pharmacists, employees, and consumers. A functional quality control program is also a requirement of Medicare Part D, many state pharmacy boards, and an increasing number of third-party private payers. Pharmacies are required

The Food and Drug Administration has recently approved the vaccines for the upcoming flu season. This year there will be one vaccine that will cover H1N1, a strain of influenza A (Perth), and a strain of influenza B (Brisbane). The

The results of a recent study indicate that the use of a calcium supplements for those treating osteoporosis leads to an increased risk of heart attack. After a smaller study indicated the increase in risk, researchers performed a meta-analysis on

The Food and Drug Administration is currently hosting a two day hearing in an attempt to gather responses on the FDA guidance that is currently given on some prescription medications. The meetings deal specifically with the Risk Evaluation and Mitigation

Pharmacist.com is the home of the American Pharmacists Accociation and features your top source for pharmacy news, pharmacist drug information, pharmacy jobs, pharmacist continuing education, and pharmacy books and resources

The Wall Street Journal has reported on links between members of the recent Avandia advisory panel and various drug makers. The advisory panel recently ruled in a 21-12 vote that the FDA should keep Avadia on the market despite links